Aging is a process of gradual decline in cellular and bodily function. Many human diseases, such as cancers, type II diabetes, neurodegenerative diseases, are either directly or indirectly associated with aging. Therefore, aging and age-associated disease can significantly influence on the quality of daily life especially within the elderly age group. Sestrin (Sesn) is a stress-inducible gene family that can be upregulated by a variety of environmental stresses including DNA damage, oxidative stresses, hypoxia and unfolded protein stresses. Sesn has two important biological activities in reducing reactive oxygen species (ROS) and suppressing mTOR complex 1 (mTORC1), both of which may attenuate aging and its associated pathologies. Indeed, in many model animals, including worms, flies and mice, Sestrin-family proteins were shown to be a critical regulator of metabolic homeostasis that attenuates diverse age- and obesity-associated pathologies. These results suggest Sestrins to be evolutionarily conserved anti-aging molecules. However, because the biochemical basis for these anti-aging activities of Sestrins has been elusive, we were unable to harness Sestrins' beneficial activities for attenuation of aging and extension of healthspan. Based on the 3D molecular structure of human Sestrin2, which we have recently determined through X-ray crystallography, here we propose to uncover the biochemical mechanisms underlying the anti-aging activity of Sestrin proteins for the first time.
In Aim 1, we will revealthe biochemical basis underlying hSesn2's antioxidant function using structure-guided mutagenesis and subsequent in vitro and in vivo assays of its redox activity.
In Aim 2, using the mutant hSesn2 proteins generated from Aim 1 research, we will examine whether the mutated residues and active sites are important for suppressing mTORC1 in cultured mammalian cells and in tissues of an intact animal (Drosophila). Finally in Aim 3, dSesn-null mutant flies, which exhibit diverse accelerated aging phenotypes, will be reconstituted with wild-type and mutant hSesn2 to test if the mutated key residue(s) are functionally important for anti-aging physiological roles of Sesn. Successful completion of the proposed research will allow us to elucidate the structural basis for the physiological function of hSesn2 in suppressing aging and controlling metabolism. The structural and mechanistic information obtained from the proposed study not only reveals the mechanisms underlying Sesns' antioxidant and mTOR-inhibiting activities, but also enables development of novel small molecules that can either enhance the catalytic activity of Sesns or increase Sesn stability. These molecules, which will be developed in future, may be used to pharmacologically expand healthspan and improve the quality-of-life in the later ages.
Aging and age-associated diseases are growing concerns in an aging society. Sestrin is a stress-inducible gene family that plays a pivotal role in antioxidan defense and mTOR regulation, both of which have been accused as major driving forces for aging. Despite the clear and ample evidence in its role in antioxidant defense and mTOR inhibition in live cells, the biochemistry of Sesn is barely understood mostly due to the lack of sequence similarity with any known enzyme family or functional domains. To overcome this, we have determined the crystal structure of human Sestrin2 and the structure strongly suggests sestrin as an antioxidant factor. In this proposed research, we attempt to uncover the detailed enzymatic mechanism of sestrin using structure-guided mutagenesis and functional assay in live cells.
| An, Sojin; Koldewey, Philipp; Chik, Jennifer et al. (2018) Mis16 Switches Function from a Histone H4 Chaperone to a CENP-ACnp1-Specific Assembly Factor through Eic1 Interaction. Structure 26:960-971.e4 |
| An, Sojin; Yoon, Jungmin; Kim, Hanseong et al. (2017) Structure-based nuclear import mechanism of histones H3 and H4 mediated by Kap123. Elife 6: |
| Ho, Allison; Cho, Chun-Seok; Namkoong, Sim et al. (2016) Biochemical Basis of Sestrin Physiological Activities. Trends Biochem Sci 41:621-632 |
| Lee, Jun Hee; Cho, Uhn-Soo; Karin, Michael (2016) Sestrin regulation of TORC1: Is Sestrin a leucine sensor? Sci Signal 9:re5 |
| Kim, Hanseong; An, Sojin; Ro, Seung-Hyun et al. (2015) Janus-faced Sestrin2 controls ROS and mTOR signalling through two separate functional domains. Nat Commun 6:10025 |
| Kim, Jeong Sig; Ro, Seung-Hyun; Kim, Myungjin et al. (2015) Sestrin2 inhibits mTORC1 through modulation of GATOR complexes. Sci Rep 5:9502 |
